Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 10;21(8):1045.
doi: 10.3390/molecules21081045.

In Vitro Antileishmanial Activity of Sterols from Trametes versicolor (Bres. Rivarden)

Affiliations

In Vitro Antileishmanial Activity of Sterols from Trametes versicolor (Bres. Rivarden)

Vivian Leliebre-Lara et al. Molecules. .

Abstract

Two ergostanes, 5α,8α-epidioxy-22E-ergosta-6,22-dien-3β-ol (1) and 5α-ergost-7,22-dien-3β-ol (2), and a lanostane, 3β-hydroxylanostan-8,24-diene-21-oic acid (trametenolic acid) (3), were isolated from an n-hexane extract prepared from the fruiting body of Trametes versicolor (Bres. Rivarden). The activity of the isolated sterols was evaluated against promastigotes and amastigotes of Leishmania amazonensis Lainson and Shaw, 1972. The lanostane, compound (3), showed the best inhibitory response (IC50 promastigotes 2.9 ± 0.1 μM and IC50 amastigotes 1.6 ± 0.1 μM). This effect was 25-fold higher compared with its cytotoxic effect on peritoneal macrophages from BALB/c mice. Therefore, trametenolic acid could be regarded as a promising lead for the synthesis of compounds with antileishmanial activity.

Keywords: Trametes versicolor; antileishmanial activity; trametenolic acid B.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Chemical structure of sterols isolated from Trametes versicolor fruiting body. Ergosterol peroxide 1; 7,22-ergostadien-3β-ol 2 and trametenolic acid B 3.

Similar articles

Cited by

References

    1. Singh N., Mishra B.B., Bajbai S., Singh R.K., Tiwari V.K. Natural product based leads to fight against leishmaniasis. Bioorg. Med. Chem. 2014;22:18–45. doi: 10.1016/j.bmc.2013.11.048. - DOI - PubMed
    1. Alvar J., Vélez I.D., Bern C., Herrero Desjeux P., Cano J., Jannin J., den Boer M., The WHO Leishmaniasis Control Team Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7:e35671. doi: 10.1371/journal.pone.0035671. - DOI - PMC - PubMed
    1. Copeland N.K., Aronson N.E. Leishmaniasis: Treatment updates and clinical practice guidelines review. Curr. Opin. Infect. Dis. 2015;28:426–437. doi: 10.1097/QCO.0000000000000194. - DOI - PubMed
    1. Sundar S., Rai M., Chakravarty J., Agarwal D., Agrawal N., Vaillant M., Olliaro P., Murray H.W. New treatment approach in Indian visceral leishmaniasis: Single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clin. Infect. Dis. 2008;47:1000–1006. doi: 10.1086/591972. - DOI - PubMed
    1. Berman J.D. Human Leishmaniasis: Clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 1997;24:684–703. doi: 10.1093/clind/24.4.684. - DOI - PubMed

MeSH terms

LinkOut - more resources